Stock Track | Day One Biopharma Soars After Smashing Q3 Earnings Estimates

Stock Track10-31

Shares of Day One Biopharmaceuticals Inc. (DAWN) skyrocketed over 7% in after-hours trading on Tuesday, following the company's impressive third-quarter earnings report that far exceeded Wall Street's expectations.

The biopharmaceutical company reported quarterly earnings of $0.38 per share, compared to analysts' consensus estimate of a loss of $0.39 per share. Day One's quarterly revenue of $93.761 million also crushed estimates of $23.545 million, marking a nearly 300% upside surprise.

The stellar financial results underscore Day One's progress in developing innovative cancer therapies and advancing its robust pipeline. Investors cheered the company's strong performance, driving the stock to surge in extended trading hours.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1133249134?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-31 04:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1133249134","market":"us","top_or_hot":-1,"title":"Stock Track | Day One Biopharma Soars After Smashing Q3 Earnings Estimates","media":"Stock Track","content":"<p>Shares of Day One Biopharmaceuticals Inc. (DAWN) skyrocketed over 7% in after-hours trading on Tuesday, following the company's impressive third-quarter earnings report that far exceeded Wall Street's expectations.</p>\n\n<p>The biopharmaceutical company reported quarterly earnings of $0.38 per share, compared to analysts' consensus estimate of a loss of $0.39 per share. Day One's quarterly revenue of $93.761 million also crushed estimates of $23.545 million, marking a nearly 300% upside surprise.</p>\n\n<p>The stellar financial results underscore Day One's progress in developing innovative cancer therapies and advancing its robust pipeline. Investors cheered the company's strong performance, driving the stock to surge in extended trading hours.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Day One Biopharma Soars After Smashing Q3 Earnings Estimates</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Day One Biopharma Soars After Smashing Q3 Earnings Estimates\n</h2>\n\n<h4 class=\"meta\">\n\n2024-10-31 04:32 北京时间&nbsp;&nbsp;&nbsp;<strong>Stock Track</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of Day One Biopharmaceuticals Inc. (DAWN) skyrocketed over 7% in after-hours trading on Tuesday, following the company's impressive third-quarter earnings report that far exceeded Wall Street's...</p>\n\n<a href=\"\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"DAWN","symbol_name":"Day One Biopharmaceuticals Inc.","start_time":0,"source_url":"","article_id":"1133249134","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1133249134","pubTimestamp":1730320377,"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Day One Biopharmaceuticals Inc.  skyrocketed over 7% in after-hours trading on Tuesday, following the company's impressive third-quarter earnings report that far exceeded Wall Street's expectations.The biopharmaceutical company reported quarterly earnings of $0.38 per share, compared to analysts' consensus estimate of a loss of $0.39 per share. Day One's quarterly revenue of $93.761 million also crushed estimates of $23.545 million, marking a nearly 300% upside surprise.The stellar fin","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"DAWN":"Day One Biopharmaceuticals Inc."},"translate_title":"股票追踪第一天生物制药公司在打破第三季度盈利预期后飙升","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DAWN":1},"content_text":"Shares of Day One Biopharmaceuticals Inc. (DAWN) skyrocketed over 7% in after-hours trading on Tuesday, following the company's impressive third-quarter earnings report that far exceeded Wall Street's expectations.\nThe biopharmaceutical company reported quarterly earnings of $0.38 per share, compared to analysts' consensus estimate of a loss of $0.39 per share. Day One's quarterly revenue of $93.761 million also crushed estimates of $23.545 million, marking a nearly 300% upside surprise.\nThe stellar financial results underscore Day One's progress in developing innovative cancer therapies and advancing its robust pipeline. Investors cheered the company's strong performance, driving the stock to surge in extended trading hours.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1133249134"}